These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12460040)

  • 1. Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis.
    Goldfarb-Rumyantzev AS; Cheung AK; Leypoldt JK
    Am J Kidney Dis; 2002 Dec; 40(6):1211-8. PubMed ID: 12460040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis.
    Leypoldt JK; Burkart JM
    Adv Perit Dial; 2002; 18():26-31. PubMed ID: 12402582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced solute removal with intermittent, in-center, 8-hour nocturnal hemodialysis.
    Troidle L; Finkelstein F; Hotchkiss M; Leypoldt JK
    Hemodial Int; 2009 Oct; 13(4):487-91. PubMed ID: 19840141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis dose and frequency.
    Locatelli F; Buoncristiani U; Canaud B; Köhler H; Petitclerc T; Zucchelli P
    Nephrol Dial Transplant; 2005 Feb; 20(2):285-96. PubMed ID: 15598667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dose of dialysis in hemodialysis patients: impact on nutrition.
    Schulman G
    Semin Dial; 2004; 17(6):479-88. PubMed ID: 15660579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled ultrafiltration (UF) with hemodialysis (HD): analysis of coupling between convective and diffusive mass transfer in a new HD-UF system.
    Kunitomo T; Lowrie EG; Kumazawa S; O'Brien M; Lazarus JM; Gottlieb MN; Merrill JP
    Trans Am Soc Artif Intern Organs; 1977; 23():234-43. PubMed ID: 910341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate.
    Kohn OF; Coe FL; Ing TS
    Hemodial Int; 2010 Jan; 14(1):39-46. PubMed ID: 19758296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of switching connection ports of double-lumen permanent tunnelled catheters on total solute removal during dialysis.
    Van Biesen W; Vanmassenhove J; Van Canneyt K; Vanholder R; Eloot S
    J Nephrol; 2011; 24(3):338-44. PubMed ID: 21374584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The consequences of physiological resistances on metabolite removal from the patient-artifical kidney system.
    Popovich RP; Hlavinka DJ; Bomar JB; Moncrief JW; Decherd JF
    Trans Am Soc Artif Intern Organs; 1975; 21():108-16. PubMed ID: 1145983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimisation of solute transport in dialysers using a three-dimensional finite volume model.
    Eloot S; Vierendeels J; Verdonck P
    Comput Methods Biomech Biomed Engin; 2006 Dec; 9(6):363-70. PubMed ID: 17145670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis adequacy indices for peritoneal dialysis and hemodialysis.
    Debowska M; Waniewski J; Lindholm B
    Adv Perit Dial; 2005; 21():94-7. PubMed ID: 16686294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model.
    Clark WR; Leypoldt JK; Henderson LW; Mueller BA; Scott MK; Vonesh EF
    J Am Soc Nephrol; 1999 Mar; 10(3):601-9. PubMed ID: 10073611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2007; 23():135-9. PubMed ID: 17886620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five years' experience of combination therapy: peritoneal dialysis with hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2002; 18():62-7. PubMed ID: 12402589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse push/pull hemodialysis: in vitro study on new dialysis modality with higher convective efficiency.
    Lee K; Lee SR; Mun CH; Min BG
    Artif Organs; 2008 May; 32(5):406-11. PubMed ID: 18471170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-microglobulin and phosphate clearances using a wearable artificial kidney: a pilot study.
    Gura V; Davenport A; Beizai M; Ezon C; Ronco C
    Am J Kidney Dis; 2009 Jul; 54(1):104-11. PubMed ID: 19376616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Middle molecules removal. Beyond beta2-microglobulin].
    Maduell F; Sánchez-Canel JJ; Blasco JA; Navarro V; Ríus A; Torregrosa E; Pin MT; Cruz C; Ferrero JA
    Nefrologia; 2006; 26(4):469-75. PubMed ID: 17058859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug dosing considerations in alternative hemodialysis.
    Decker BS; Mueller BA; Sowinski KM
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e17-26. PubMed ID: 17603971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimodal dialysis: theoretical and computational investigations of adequacy indices for combined use of peritoneal dialysis and hemodialysis.
    Debowska M; Waniewski J; Lindholm B
    ASAIO J; 2007; 53(5):566-75. PubMed ID: 17885329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.